{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T10:41:57Z","timestamp":1771670517393,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T00:00:00Z","timestamp":1631923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T00:00:00Z","timestamp":1631923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18K09351"],"award-info":[{"award-number":["18K09351"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p><jats:italic>Mycobacterium abscessus subspecies massiliense<\/jats:italic> is a non-tuberculous mycobacteriosis and was subdivided from <jats:italic>Mycobacterium <\/jats:italic><jats:italic>abscessus<\/jats:italic> in 2006. This article is the first report on nasopharyngitis caused by <jats:italic>Mycobacterium abscessus subspecies massiliense<\/jats:italic>.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 45-year-old woman had an 18-month history of recurrent nasopharyngitis and presented with pain in the throat. Mycobacterial tissue culture and polymerase chain reaction testing revealed the presence of <jats:italic>Mycobacterium abscessus subspecies massiliense<\/jats:italic> in the nasopharyngeal tissue. This patient underwent surgery, followed by multiple rounds of chemotherapy with oral and intravenous antibiotic agents for 16\u00a0weeks. She has had no recurrence during the 56\u00a0weeks since treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>It is difficult to detect the presence of <jats:italic>Mycobacterium abscessus subspecies massiliense<\/jats:italic> in a culture from the swabbing sample. The tissue culture from a biopsy specimen is mandatory for the identification of the species. Currently, no definite treatment policy is available and only empirical treatment is applied. This case is an important for the diagnosis and treatment of this bacterial infection on nasopharynx.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40001-021-00578-8","type":"journal-article","created":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T17:02:47Z","timestamp":1631984567000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A first case report of nasopharyngeal Mycobacterium abscessus subspecies massiliense infection"],"prefix":"10.1186","volume":"26","author":[{"given":"Yamato","family":"Oki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6068-5289","authenticated-orcid":false,"given":"Hiromitsu","family":"Hatakeyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Isono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetaka","family":"Ikemiyagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Tsukiji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoko","family":"Higa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiko","family":"Oridate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,18]]},"reference":[{"issue":"4","key":"578_CR1","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","volume":"175","author":"DE Griffith","year":"2007","unstructured":"Griffith DE, et al. An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367\u2013416.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"578_CR2","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1055\/s-0038-1651494","volume":"39","author":"L Strnad","year":"2018","unstructured":"Strnad L, Winthrop KL. Treatment of Mycobacterium abscessus complex. Semin Respir Crit Care Med. 2018;39(3):362\u201376.","journal-title":"Semin Respir Crit Care Med"},{"issue":"7","key":"578_CR3","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1128\/JCM.01688-08","volume":"47","author":"AM Zelazny","year":"2009","unstructured":"Zelazny AM, et al. Cohort study of molecular identification and typing of Mycobacterium abscessus, Mycobacterium massiliense, and Mycobacterium bolletii. J Clin Microbiol. 2009;47(7):1985\u201395.","journal-title":"J Clin Microbiol"},{"issue":"12","key":"578_CR4","first-page":"923","volume":"86","author":"K Atsuyuki","year":"2011","unstructured":"Atsuyuki K. Treatment of relatively rare species nontuberculous pulmonary mycobacteriosis. Kekkaku. 2011;86(12):923\u201332.","journal-title":"Kekkaku"},{"issue":"9","key":"578_CR5","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.3201\/2109.141634","volume":"21","author":"MR Lee","year":"2015","unstructured":"Lee MR, Sheng WH, Hung CC, Yu CJ, Lee LN, Hsueh PR. Mycobacterium abscessus complex infections in humans. Emerg Infect Dis. 2015;21(9):1638\u201346.","journal-title":"Emerg Infect Dis"},{"key":"578_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ijid.2018.06.019","volume":"74","author":"S Myojin","year":"2018","unstructured":"Myojin S, et al. Chronic otitis media caused by Mycobacterium abscessus spp. massiliense treated with tigecycline in a 10-year-old child. Int J Infect Dis. 2018;74:10\u20132.","journal-title":"Int J Infect Dis"},{"key":"578_CR7","doi-asserted-by":"publisher","DOI":"10.4172\/1948-5964.1000168","author":"O Hotta","year":"2017","unstructured":"Hotta O, Inoue N, Tanaka A, Ieiri N. Possible mechanisms underlying epipharyngeal abrasive therapy (EAT) with ZnCl2 solution for the treatment of autoimmune diseases and functional somatic syndrome. J Antivir Antiretrovir. 2017. https:\/\/doi.org\/10.4172\/1948-5964.1000168.","journal-title":"J Antivir Antiretrovir"},{"issue":"1","key":"578_CR8","first-page":"69","volume":"31","author":"H Osamu","year":"2018","unstructured":"Osamu H, Chiyoko N. Various pathological conditions suggesting association of chronic epipharyngitis and the putative mechanism of epipharyngeal abrasive therapy. Jpn Soc Stomato Pharyngol. 2018;31(1):69\u201375.","journal-title":"Jpn Soc Stomato Pharyngol"},{"issue":"1","key":"578_CR9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1128\/JCM.01327-13","volume":"52","author":"N Kazue","year":"2014","unstructured":"Kazue N, et al. Discrimination of Mycobacterium abscessus subsp. massiliense from Mycobacterium abscessus subsp. abscessus in clinical isolates by multiplex PCR. J Clin Microbiol . 2014;52(1):251\u20139.","journal-title":"J Clin Microbiol"},{"key":"578_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.103187","volume":"64","author":"Y Mitsunori","year":"2021","unstructured":"Mitsunori Y, Sotaro S, Jung CH, Hanako F, Masato S. A novel DNA chromatography method to discriminate Mycobacterium abscessus subspecies and macrolide susceptibility. EBioMedicine. 2021;64: 103187.","journal-title":"EBioMedicine"},{"key":"578_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/5.4.657","author":"RJ Wallace Jr","year":"1983","unstructured":"Wallace RJ Jr, Swenson JM, Silcox VA, Good RC, Tschen JA, Stone MS. Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis. 1983. https:\/\/doi.org\/10.1093\/clinids\/5.4.657.","journal-title":"Rev Infect Dis"},{"issue":"6","key":"578_CR12","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S0002-9394(01)01267-3","volume":"132","author":"NS Chandra","year":"2001","unstructured":"Chandra NS, et al. Cluster of Mycobacterium chelonae keratitis cases following laser in-situ keratomileusis. Am J Ophthalmol. 2001;132(6):819\u201330.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"578_CR13","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/infdis\/147.3.427","volume":"147","author":"HW Clegg","year":"1983","unstructured":"Clegg HW, Foster MT, Sanders WE, Baine WB. Infection due to organisms of the Mycobacterium fortuitum complex after augmentation mammaplasty: clinical and epidemiologic features. J Infect Dis. 1983;147(3):427\u201333.","journal-title":"J Infect Dis"},{"issue":"4","key":"578_CR14","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1093\/infdis\/159.4.708","volume":"159","author":"RJ Wallace","year":"1989","unstructured":"Wallace RJ, et al. Diversity and sources of rapidly growing mycobacteria associated with infections following cardiac surgery. J Infect Dis. 1989;159(4):708\u201316.","journal-title":"J Infect Dis"},{"issue":"10","key":"578_CR15","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1128\/jcm.31.10.2697-2701.1993","volume":"31","author":"RJ Wallace","year":"1993","unstructured":"Wallace RJ, Zhang Y, Brown BA, Fraser V, Mazurek GH, Maloney S. DNA large restriction fragment patterns of sporadic and epidemic nosocomial strains of Mycobacterium chelonae and Mycobacterium abscessus. J Clin Microbiol. 1993;31(10):2697\u2013701.","journal-title":"J Clin Microbiol"},{"issue":"15","key":"578_CR16","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1056\/NEJM198810133191504","volume":"319","author":"PW Lowry","year":"1988","unstructured":"Lowry PW, et al. Mycobacterium chelonae causing otitis media in an ear-nose-and-throat practice. N Engl J Med. 1988;319(15):978\u201382.","journal-title":"N Engl J Med"},{"issue":"5","key":"578_CR17","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1128\/jcm.30.5.1250-1255.1992","volume":"30","author":"JSR Hector","year":"1992","unstructured":"Hector JSR, Pang Y, Mazurek GH, Zhang Y, Brown BA, Wallace RJ. Large restriction fragment patterns of genomic Mycobacterium fortuitum DNA as strain-specific markers and their use in epidemiologic investigation of four nosocomial outbreaks. J Clin Microbiol. 1992;30(5):1250\u20135.","journal-title":"J Clin Microbiol"},{"issue":"5","key":"578_CR18","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1093\/infdis\/152.5.1013","volume":"152","author":"G Bolan","year":"1985","unstructured":"Bolan G, et al. Infections with Mycobacterium chelonei in patients receiving dialysis and using processed hemodialyzers. J Infect Dis. 1985;152(5):1013\u20139.","journal-title":"J Infect Dis"},{"key":"578_CR19","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1146\/annurev.micro.52.1.453","volume":"52","author":"RJ Wallace","year":"1998","unstructured":"Wallace RJ, Brown BA, Griffith DE. Nosocomial outbreaks\/pseudo-outbreaks caused by nontuberculous mycobacteria. Annu Rev Microbiol. 1998;52:453\u201390.","journal-title":"Annu Rev Microbiol"},{"issue":"6","key":"578_CR20","first-page":"463","volume":"92","author":"J Daisuke","year":"2017","unstructured":"Daisuke J, et al. A case of infection with Mycobacterium massiliense in a patient who had long-term untreated Mycobacterium avium complex pulmonary disease. Kekkaku. 2017;92(6):463\u20137.","journal-title":"Kekkaku"},{"issue":"3","key":"578_CR21","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0272-5231(02)00014-X","volume":"23","author":"JO Falkinham","year":"2002","unstructured":"Falkinham JO. Nontuberculous mycobacteria in the environment. Clin Chest Med. 2002;23(3):529\u201351.","journal-title":"Clin Chest Med"},{"issue":"12","key":"578_CR22","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1128\/jcm.31.12.3227-3230.1993","volume":"31","author":"CF Von Reyn","year":"1993","unstructured":"Von Reyn CF, et al. Isolation of Mycobacterium avium complex from water in the United States, Finland, Zaire, and Kenya. J Clin Microbiol. 1993;31(12):3227\u201330.","journal-title":"J Clin Microbiol"},{"issue":"5","key":"578_CR23","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1164\/ajrccm\/147.5.1271","volume":"147","author":"DE Griffith","year":"1993","unstructured":"Griffith DE, Girard WM, Wallace RJ. Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients. Am Rev Respir Dis. 1993;147(5):1271\u20138.","journal-title":"Am Rev Respir Dis"},{"key":"578_CR24","unstructured":"Wayne PA et al. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes Approved Standard. NCCLS. 2003;M24-A."},{"issue":"1","key":"578_CR25","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1128\/AAC.36.1.180","volume":"36","author":"BA Brown","year":"1992","unstructured":"Brown BA, Wallace RJ, Onyi G, Rosas VDE, Wallace RJ. Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms. Antimicrob Agents Chemother. 1992;36(1):180\u20134.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"578_CR26","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1128\/AAC.28.6.807","volume":"28","author":"JM Swenson","year":"2000","unstructured":"Swenson JM, Wallace RJ, Silcox VA, Thornsberry C. Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae. Antimicrob Agents Chemother. 2000;28(6):807\u201311.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"578_CR27","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1128\/AAC.24.4.486","volume":"24","author":"S Mary","year":"1983","unstructured":"Mary S, Christensen LA, Wallace RJ, Swenson JM, Thornsberry C. Agar disk elution method for susceptibility testing of Mycobacterium marinum and Mycobacterium fortuitum complex to sulfonamides and antibiotics. Antimicrob Agents Chemother. 1983;24(4):486\u201393.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"578_CR28","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1128\/AAC.35.4.773","volume":"35","author":"RJ Wallace","year":"1991","unstructured":"Wallace RJ, Brown BA, Onyi G. Susceptibilities of Mycobacterium fortuitum biovar. fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid. Antimicrob Agents Chemother. 1991;35(4):773\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"578_CR29","doi-asserted-by":"publisher","DOI":"10.1086\/420742","author":"CA Peloquin","year":"2004","unstructured":"Peloquin CA, et al. Aminoglycoside toxicity\u202f: daily versus thrice-weekly dosing for treatment of mycobacterial diseases. Clin Infect Dis. 2004. https:\/\/doi.org\/10.1086\/420742.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"578_CR30","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/infdis\/166.2.405","volume":"166","author":"RJ Wallace","year":"1992","unstructured":"Wallace RJ, Brown BA, Onyi GO. Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. J Infect Dis. 1992;166(2):405\u201312.","journal-title":"J Infect Dis"},{"issue":"11","key":"578_CR31","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1128\/JCM.01175-12","volume":"50","author":"T Harada","year":"2012","unstructured":"Harada T, et al. Clinical and microbiological differences between Mycobacterium abscessus and Mycobacterium massiliense lung diseases. J Clin Microbiol. 2012;50(11):3556\u201361.","journal-title":"J Clin Microbiol"},{"issue":"11","key":"578_CR32","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/j.rmed.2014.09.002","volume":"108","author":"J Lyu","year":"2014","unstructured":"Lyu J, et al. A shorter treatment duration may be sufficient for patients with Mycobacterium massiliense lung disease than with Mycobacterium abscessus lung disease. Respir Med. 2014;108(11):1706\u201312.","journal-title":"Respir Med"},{"issue":"3","key":"578_CR33","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/cid\/ciw723","volume":"64","author":"J Park","year":"2017","unstructured":"Park J, Cho J, Lee CH, Han SK, Yim JJ. Progression and treatment outcomes of lung disease caused by Mycobacterium abscessus and Mycobacterium massiliense. Clin Infect Dis. 2017;64(3):301\u20138.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"578_CR34","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1164\/rccm.201003-0395OC","volume":"183","author":"W Koh","year":"2011","unstructured":"Koh W, et al. Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus. Am J Respir Crit Care Med. 2011;183(3):405\u201310.","journal-title":"Am J Respir Crit Care Med"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-021-00578-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-021-00578-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-021-00578-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T17:03:50Z","timestamp":1631984630000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-021-00578-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,18]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["578"],"URL":"https:\/\/doi.org\/10.1186\/s40001-021-00578-8","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,18]]},"assertion":[{"value":"11 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our institution\u2019s Research Ethics Board does not require a review or approval for case reports.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient consented to the publication of this case report and written informed consent was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"109"}}